$USPH Cashflow Statement | Understand Stock

$USPH

$87.34 -$1.31 (1.48%) Close

$USPH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
OPERATING ACTIVITIES
Net income including non-controlling interest
Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:
Depreciation and amortization
Provision for credit losses
Equity-based awards compensation expense
Deferred income taxes
Amortization of debt issue costs
Change in deferred income taxes
Gain on sale of partnership interest
Derecognition (write-off) of goodwill - closed clinics
Change in revaluation of put-right liability
Change in fair value of contingent earn-out consideration
Equity of earnings in unconsolidated affiliate
Loss on sale of clinics and fixed assets
Impairment of Goodwill
Loss on sale of partnership
Impairment of goodwill and other intangible assets
Impairment of assets held for sale
Other

Changes in operating assets and liabilities:
Patient accounts receivable, net
Accounts receivable - other
Other current and long term assets
Accounts payable and accrued expenses
Other long-term liabilities
Net cash provided by operating activities
INVESTING ACTIVITIES
Purchase of fixed assets
Purchase of majority interest in businesses, net of cash acquired
Purchase of redeemable non-controlling interest, temporary equity
Purchase of non controlling interest, permanent equity
Proceeds on sale of non-controlling interest, permanent equity
Repayment of notes receivable related to sales of redeemable non-controlling interest
Proceeds on sale of partnership interest - redeemable non-controlling interest, temporary equity
Proceeds on sales of partnership interest, clinics and fixed assets
Distributions from unconsolidated affiliate
Proceeds on sale of partnership interest, clinics and fixed assets
Other
Net cash used in investing activities

FINANCING ACTIVITIES
Proceeds from revolving facility
Distributions to non-controlling interest, permanent and temporary equity
Cash dividends paid to shareholders
Payments on term loan
Proceeds from term loan
Payment of deferred financing costs
Payment of Medicare Accelerated and Advance Funds
Other
Cash used for the repurchase of common stock
Principal payments on notes payable
(Payment) receipt of Medicare Accelerated and Advance Funds
Net cash (used in) provided by financing activities

Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents - beginning of period
Cash and cash equivalents - end of period
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid during the period for:
Income taxes
Interest paid
Non-cash investing and financing transactions during the period:
Purchase of businesses - seller financing portion
Purchase of business - payable to common shareholders of acquired business
Liabilities assumed associated with a purchase of a business
Fair market value of initial contingent consideration related to purchase of businesses
Notes payable related to purchase of redeemable non-controlling interest, temporary equity
Payable related to the purchase of redeemable non-controlling interest, temporary equity
Offset to notes receivable associated with purchase of redeemable non-controlling interest
Notes receivable related to sale of redeemable non-controlling interest
Notes receivable related to sale of partnership interest
Notes payable related to the purchase of non-controlling interest, permanent equity
Payable related to the purchase of non-controlling interest, permanent equity
Notes receivable related to the sale of non-controlling interest, permanent equity
Issuance of restricted stock related to purchase of business

Comments